CancerTools.org has an extensive portfolio of nearly 1000 cell lines from various species, tissues, and cancer types. They have been sourced internationally from leading research laboratories and institutes.
The portfolio contains human cancer cell lines resistant to many of the commonly used chemotherapeutic drugs for use in the development of alternative inhibitors. In addition, there are cell lines resistant to anti-metabolites, DNA-interacting agents, inhibitors of signal transduction and hormone receptor-mediated proliferation.
The portfolio includes cell lines that have been altered using gene-editing technologies to provide either gene knock-outs or knock-ins.
There are cell lines transformed with target or reporter genes for gene function studies in cancer biology, apoptosis & autophagy, drug discovery, cell signalling and signal transduction.
Maintained and managed by CancerTools.org, we aim to make all cell lines available to all researchers within the global scientific community.